Your browser doesn't support javascript.
loading
Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy.
Pinnix, Chelsea C; Gunther, Jillian R; Fang, Penny; Bankston, Mikaela E; Milgrom, Sarah A; Boyce, David; Lee, Hun Ju; Nair, Ranjit; Steiner, Raphael; Strati, Paolo; Ahmed, Sairah; Iyer, Swaminathan P; Westin, Jason; Parmar, Simrit; Rodriguez, M Alma; Nastoupil, Loretta; Neelapu, Sattva; Flowers, Christopher; Dabaja, Bouthaina S.
Afiliação
  • Pinnix CC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Gunther JR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Fang P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Bankston ME; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Milgrom SA; Department of Radiation Oncology, University of Colorado, Denver.
  • Boyce D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Lee HJ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Nair R; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Steiner R; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Strati P; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Ahmed S; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Iyer SP; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Westin J; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Parmar S; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Rodriguez MA; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Nastoupil L; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Neelapu S; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Flowers C; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.
  • Dabaja BS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston.
JAMA Netw Open ; 3(9): e2013935, 2020 09 01.
Article em En | MEDLINE | ID: mdl-32990738
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doses de Radiação / Radioterapia / Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Órgãos em Risco / Efeitos Adversos de Longa Duração Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doses de Radiação / Radioterapia / Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Órgãos em Risco / Efeitos Adversos de Longa Duração Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article